Retatrutide: Status, Market Outlook & Country-Launch Playbook
Where Lilly's triple-hormone obesity drug stands, what its arrival means for markets worldwide, and a step-by-step framework for bringing it — or a competitor — to a new country.
iPharmag Intelligence
Pharma market research, forecasts & launch playbooks
Decision-grade analysis for pharma teams worldwide — drug status, market outlook, and country-by-country launch strategy. Public summaries are free to read; full reports are free while in beta after a quick sign-up.